No safety problems, no efficacy concerns just a bit of feeling around to get get the edge of the patient group.
NO COMPETITORS.TOP PRIORITY UNMET NEED. MASSIVE MARKET SIZE.
Cant stay under the $100 for ever.
- Forums
- ASX - By Stock
- SHC
- A gentlemanly dispute
A gentlemanly dispute, page-4
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online